Sort
17,054 grants matching “genome editing”
Structure and Activation of a Multiprotein Signaling Complex
$694,073Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2018 · AI
Roles for uniquely human enhancers in brain development and WNT signaling
$694,047Debra Silver · Duke University · R01 · FY2024 · MH
Function-based exploration of genetic variation at genome-scale
$694,040Lars M Steinmetz · Stanford University · R01 · FY2024 · HG
Function-based exploration of genetic variation at genome-scale
$694,040Lars M Steinmetz · Stanford University · R01 · FY2025 · HG
Streamlined development of an IND with the silica nanocapsule loaded with Cas9 genome editors to disrupt the dominant BEST1 mutant allele
$693,945Krishanu Saha · University Of Wisconsin-Madison · U19 · FY2024 · NS
Collaborative Research: Reversing evolution to understand the genetic basis of species divergence
$693,850Carlos A Machado · University Of Maryland, College Park · · FY2018 · BIO
Large scale nutrigenetics and genomics in a tractable metazoan model
$693,788Albertha Johanna Walhout · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · DK
Defining mechanisms of aortic root aneurysm in Loeys-Dietz syndrome using patientsâ induced pluripotent stem cells and genome editing
$693,571Bo Yang · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Defining mechanisms of aortic root aneurysm in Loeys-Dietz syndrome using patientsâ induced pluripotent stem cells and genome editing
$693,571Bo Yang · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
Defining mechanisms of aortic root aneurysm in Loeys-Dietz syndrome using patientsâ induced pluripotent stem cells and genome editing
$693,571Bo Yang · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
Defining mechanisms of aortic root aneurysm in Loeys-Dietz syndrome using patientsâ induced pluripotent stem cells and genome editing
$693,571Bo Yang · University Of Michigan At Ann Arbor · R01 · FY2021 · HL
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies
$693,457Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Mapping, modeling, and manipulating 3D contacts in vascular cells to connect risk variants to disease genes
$693,228Jesse M Engreitz · Stanford University · R01 · FY2023 · HL
Mapping, modeling, and manipulating 3D contacts in vascular cells to connect risk variants to disease genes
$693,192Jesse M Engreitz · Stanford University · R01 · FY2025 · HL
Post-transcriptional Regulatory Networks
$692,945Quaid Morris · Sloan-Kettering Inst Can Research · R01 · FY2023 · HG
Collaborative Research: Deep-sequencing analysis of edited metabolic pathways to uncover, model, and overcome the epistatic constraints upon optimization
$692,761Christopher J Marx · Regents Of The University Of Idaho · · FY2017 · BIO
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction
$692,459Yigang Wang · University Of Cincinnati · R01 · FY2021 · HL
Structure and Activation of a Multiprotein Signaling Complex
$692,071Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2020 · AI
Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells
$692,040Jacques F Banchereau · Jackson Laboratory · U01 · FY2016 · AI
Structure and Activation of a Multiprotein Signaling Complex
$691,950Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2021 · AI
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis
$691,846Frank D. McKeon · University Of Houston · R01 · FY2022 · HL
ASB13 Control of EBV Life Cycle in B Cell and Epithelial Cell Cancers
$691,788Renfeng Li · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Development of platforms for sorting, production, editing of beta cells
$691,470Amit Choudhary · Broad Institute, Inc. · R01 · FY2023 · DK
Neuronal Vulnerability to Lipid Droplets and Cholesterol in Alzheimer's Disease
$691,408Jubao Duan · Endeavor Health Clinical Operations · R01 · FY2023 · AG
Neuronal Vulnerability to Lipid Droplets and Cholesterol in Alzheimer's Disease
$691,408Jubao Duan · Endeavor Health Clinical Operations · R01 · FY2024 · AG